Penafian

Medical disclaimer

The CRISPR Atlas provides educational information about gene editing. It does not provide medical advice, diagnosis or treatment. Nothing on this website is a substitute for the judgement of a qualified healthcare professional who knows your situation, and nothing here should be used to start, stop or change any treatment.

Information about an experimental therapy is not evidence that the therapy is safe or effective. A treatment being in preclinical work, in a clinical trial, or under regulatory review tells you that it is being studied — nothing more. Most treatments that enter clinical trials are never approved. Early results in small numbers of people frequently do not hold up in larger studies or over longer follow-up.

Clinical-trial status, regulatory status and product availability change frequently and are not the same in every country. Every record on this site carries a last-updated date; treat it as a compiled snapshot and verify current status with the regulator, the trial registry or your clinician.

This site cannot enrol you in a clinical trial, assess your eligibility for one, or refer you to a study. Eligibility is determined by trial investigators. If you are considering a trial, discuss it with your own clinician and consult the official registry for the country concerned.

If you have a medical emergency, contact your local emergency services immediately. Do not rely on anything you read here.

Investment disclaimer

The investing section and all company information on this website are provided for educational purposes only. Nothing on this website is investment advice, nor does it represent a recommendation that any particular security, portfolio, transaction or investment strategy is suitable for any specific person. The CRISPR Atlas is not a registered investment adviser, broker-dealer, or financial planner, and no communication here should be construed as a solicitation to buy or sell any security.

Biotechnology investments can be highly speculative. Clinical success is uncertain: most development programmes fail, single trial readouts can change a company's value dramatically, and scientific significance does not reliably translate into commercial success. Users should conduct their own independent research and consult professional advisers before making any financial decision.

Company records are compiled from public disclosures and are not live financial data. We do not publish share prices or market capitalisations, because a figure that is stale by minutes is worse than no figure at all.

Scientific and data limitations

Scientific values carry inherent uncertainty and are revised as research advances. Prevalence figures, efficiency rates and outcome numbers depend heavily on the population, the assay and the definition used, and differ between sources. Data compiled here may be incomplete, delayed, or revised — always verify against the primary sources named on each page before relying on any of it.

AI-assisted content

Portions of this site's content and data compilation are produced with AI-assisted research; figures are indicative and may be out of date — always verify with primary sources. The Ask the Atlas assistant answers only from records held on this site and can still paraphrase them inaccurately; follow the links it gives you.

Legal information

Summaries of law and regulation on this site — including on the ethics and agriculture pages — are provided for orientation only and are not legal advice. Law differs by jurisdiction, changes over time, and is often implemented differently in practice than the headline rule suggests.

Limitation of liability

All viewers agree that under no circumstances will The CRISPR Atlas, its operators, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained here. By visiting, using, or viewing this site, you agree to its Terms of Use and Privacy Policy.

External links and advertising

Links to publishers, regulators, registries and companies are provided for reference. We do not control and are not responsible for the content of external sites. This site carries no affiliate links at present; should any be added, the relationship will be disclosed clearly on every page carrying them, as required by the U.S. Federal Trade Commission's endorsement guidelines. Advertising, where shown, is served by Google AdSense and does not influence editorial content.

Copyright

Content on this site is provided for informational purposes. News headlines link to, and remain the property of, their original publishers. Research summaries are our own words; the underlying papers remain the property of their authors and publishers. © 2026 The CRISPR Atlas.